sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / AI for Pharmaceutical

AI for Pharmaceutical Market By Offering (Software, Services), By Technology (Context-Aware Processing, Natural Language Processing, Machine learning, and Deep Learning), and By Application (Drug Discovery, Research & Development, Diagnosis, Epidemic Prediction, Disease Prevention, Remote Monitoring, Manufacturing, and Marketing): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

  • Publish On: Mar-2021
  • Total Pages: 225
  • Report Code: FAF-1408
  • Base Year: 2020
  • Format:

Industry Insights

[225+ Pages Report] According to the report published by Facts & Factors, the global AI for Pharmaceutical market was valued at approximately USD 550 Million in 2019, and is expected to generate revenue of around USD 8150 Million by 2026, growing at a CAGR of around 47% between 2020 and 2026.

Global AI for Pharmaceutical Market: Overview              

AI in pharmaceutical applications refers to the system of automated and interconnected technologies that are able to function autonomously and requires a very minute or no human interventions. AI analyses the colossal amount of data by utilizing techniques like deep learning, machine learning, adaptive learning, natural language processing, and computer vision. Both the biopharmaceutical and pharmaceutical companies are leveraging AI for various applications including drug development, drug discovery, and drug commercialization.

Global AI for Pharmaceutical Market: Growth Factors

The increasing adoption of artificial intelligence platforms (AIs) to reduce the overall cost of drug discovery and to boost the results is expected to boost pharmaceutical demand for these platforms. Moreover, the ease of obtaining monumental data through preclinical research and molecular screening is propelling the adoption of artificial intelligence in pharma applications. Furthermore, the accessibility of myriad options for gathering information and customization of artificial intelligence platforms is encouraging pharma companies to leverage artificial intelligence. The advancement in artificial intelligence technology enables companies to accurately recognize the molecular binding characteristics of the drug.

Global AI for Pharmaceutical Market: Segmentation

The AI for Pharmaceutical market has been analyzed into the offering, technology, and application. The offering segment has been classified into software, and services. The software segment dominants the market in 2019 owing to certain advantages such as low cost and accelerate time to market the drug. Moreover, higher demand for the software among the larger pharma, biotech manufacturer, and research institutes are significantly influencing the growth of the segment. On the basis of technology, the market has been analyzed into natural language processing, context-aware processing, deep learning, and machine learning. In terms of application, the industry has been bifurcated into manufacturing, remote monitoring, research & development, drug discovery, epidemic prediction, diagnosis, disease prevention, and marketing.

Global AI for Pharmaceutical Market: Regional Analysis

Geographically, North America is dominating the global market for AI for pharmaceutical. The regional market share is mainly driven by U.S. and Canada; massive investments in AI technologies and a large number of cross-industry strategic collaborations majorly fuel the growth of the AI for pharmaceutical market. Additionally, the presence of major market contributors such as Google, IBM, NVIDIA, Microsoft, and Intel, are headquartered in this region which is aiding the market to grow. However, Asia-Pacific is expected to register the highest CAGR growth over the projected period, owing to the rise in adoption of advanced AI technologies and the focus of major players on expanding their market presence in emerging countries of Asia. Thereby, certain factors are responsible for the large share and high growth rate of this market.

Global AI for Pharmaceutical Market: Competitive Players

Some main participants of the AI for Pharmaceutical market are Pfizer, Janssen Pharmaceutical, Sanofi, Novartis, Bayer, Takeda, Roche, Merck, Glaxo SmithKline, Eli Lilly, Astra Zeneca, and Allergan among others

AI for Pharmaceutical Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of AI for Pharmaceutical
    2. 1.2. Global AI for Pharmaceutical Market, 2019 & 2026 (USD Million)
    3. 1.3. Global AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    4. 1.4. Global AI for Pharmaceutical Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
    5. 1.5. Global AI for Pharmaceutical Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
  2. Chapter 2 AI for Pharmaceutical Market – Offering Analysis
    1. 2.1. Global AI for Pharmaceutical Market – Offering Overview
    2. 2.2. Global AI for Pharmaceutical Market Share, by Offering, 2019 & 2026 (USD Million)
    3. 2.3. Software
      1. 2.3.1. Global Software AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    4. 2.4. Services
      1. 2.4.1. Global Services AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
  3. Chapter 3 AI for Pharmaceutical Market – Technology Analysis
    1. 3.1. Global AI for Pharmaceutical Market – Technology Overview
    2. 3.2. Global AI for Pharmaceutical Market Share, by Technology, 2019 & 2026 (USD Million)
    3. 3.3. Context-Aware Processing
      1. 3.3.1. Global Context-Aware Processing AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    4. 3.4. Natural Language Processing
      1. 3.4.1. Global Natural Language Processing AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    5. 3.5. Machine Learning
      1. 3.5.1. Global Machine Learning AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    6. 3.6. Deep Learning
      1. 3.6.1. Global Deep Learning AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
  4. Chapter 4 AI for Pharmaceutical Market – Application Analysis
    1. 4.1. Global AI for Pharmaceutical Market – Application Overview
    2. 4.2. Global AI for Pharmaceutical Market Share, by Application, 2019 & 2026 (USD Million)
    3. 4.3. Drug Discovery
      1. 4.3.1. Global Drug Discovery AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    4. 4.4. Research & Development
      1. 4.4.1. Global Research & Development AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    5. 4.5. Diagnosis
      1. 4.5.1. Global Diagnosis AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    6. 4.6. Epidemic Prediction
      1. 4.6.1. Global Epidemic Prediction AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    7. 4.7. Disease Prevention
      1. 4.7.1. Global Disease Prevention AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    8. 4.8. Remote Monitoring
      1. 4.8.1. Global Remote Monitoring AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    9. 4.9. Manufacturing
      1. 4.9.1. Global Manufacturing AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    10. 4.10. Marketing
      1. 4.10.1. Global Marketing AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
  5. Chapter 5 AI for Pharmaceutical Market – Regional Analysis
    1. 5.1. Global AI for Pharmaceutical Market Regional Overview
    2. 5.2. Global AI for Pharmaceutical Market Share, by Region, 2019 & 2026 (USD Million)
    3. 5.3. North America
      1. 5.3.1. North America AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
        1. 5.3.1.1. North America AI for Pharmaceutical Market, by Country, 2016 - 2026 (USD Million)
      2. 5.3.2. North America AI for Pharmaceutical Market, by Offering, 2016 – 2026
        1. 5.3.2.1. North America AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      3. 5.3.3. North America AI for Pharmaceutical Market, by Technology, 2016 – 2026
        1. 5.3.3.1. North America AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.3.4. North America AI for Pharmaceutical Market, by Application, 2016 – 2026
        1. 5.3.4.1. North America AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      5. 5.3.5. U.S.
        1. 5.3.5.1. U.S. AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      6. 5.3.6. Canada
        1. 5.3.6.1. Canada AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    4. 5.4. Europe
      1. 5.4.1. Europe AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
        1. 5.4.1.1. Europe AI for Pharmaceutical Market, by Country, 2016 - 2026 (USD Million)
      2. 5.4.2. Europe AI for Pharmaceutical Market, by Offering, 2016 – 2026
        1. 5.4.2.1. Europe AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      3. 5.4.3. Europe AI for Pharmaceutical Market, by Technology, 2016 – 2026
        1. 5.4.3.1. Europe AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.4.4. Europe AI for Pharmaceutical Market, by Application, 2016 – 2026
        1. 5.4.4.1. Europe AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      5. 5.4.5. Germany
        1. 5.4.5.1. Germany AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      6. 5.4.6. France
        1. 5.4.6.1. France AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      7. 5.4.7. U.K.
        1. 5.4.7.1. U.K. AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      8. 5.4.8. Italy
        1. 5.4.8.1. Italy AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      9. 5.4.9. Spain
        1. 5.4.9.1. Spain AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      10. 5.4.10. Rest of Europe
        1. 5.4.10.1. Rest of Europe AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
        1. 5.5.1.1. Asia Pacific AI for Pharmaceutical Market, by Country, 2016 - 2026 (USD Million)
      2. 5.5.2. Asia Pacific AI for Pharmaceutical Market, by Offering, 2016 – 2026
        1. 5.5.2.1. Asia Pacific AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      3. 5.5.3. Asia Pacific AI for Pharmaceutical Market, by Technology, 2016 – 2026
        1. 5.5.3.1. Asia Pacific AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.5.4. Asia Pacific AI for Pharmaceutical Market, by Application, 2016 – 2026
        1. 5.5.4.1. Asia Pacific AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      5. 5.5.5. China
        1. 5.5.5.1. China AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      6. 5.5.6. Japan
        1. 5.5.6.1. Japan AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      7. 5.5.7. India
        1. 5.5.7.1. India AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      8. 5.5.8. South Korea
        1. 5.5.8.1. South Korea AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      9. 5.5.9. South-East Asia
        1. 5.5.9.1. South-East Asia AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      10. 5.5.10. Rest of Asia Pacific
        1. 5.5.10.1. Rest of Asia Pacific AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    6. 5.6. Latin America
      1. 5.6.1. Latin America AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
        1. 5.6.1.1. Latin America AI for Pharmaceutical Market, by Country, 2016 - 2026 (USD Million)
      2. 5.6.2. Latin America AI for Pharmaceutical Market, by Offering, 2016 – 2026
        1. 5.6.2.1. Latin America AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      3. 5.6.3. Latin America AI for Pharmaceutical Market, by Technology, 2016 – 2026
        1. 5.6.3.1. Latin America AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.6.4. Latin America AI for Pharmaceutical Market, by Application, 2016 – 2026
        1. 5.6.4.1. Latin America AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      5. 5.6.5. Brazil
        1. 5.6.5.1. Brazil AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      6. 5.6.6. Mexico
        1. 5.6.6.1. Mexico AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      7. 5.6.7. Rest of Latin America
        1. 5.6.7.1. Rest of Latin America AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
        1. 5.7.1.1. The Middle-East and Africa AI for Pharmaceutical Market, by Country, 2016 - 2026 (USD Million)
      2. 5.7.2. The Middle-East and Africa AI for Pharmaceutical Market, by Offering, 2016 – 2026
        1. 5.7.2.1. The Middle-East and Africa AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      3. 5.7.3. The Middle-East and Africa AI for Pharmaceutical Market, by Technology, 2016 – 2026
        1. 5.7.3.1. The Middle-East and Africa AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.7.4. The Middle-East and Africa AI for Pharmaceutical Market, by Application, 2016 – 2026
        1. 5.7.4.1. The Middle-East and Africa AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      5. 5.7.5. GCC Countries
        1. 5.7.5.1. GCC Countries AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      6. 5.7.6. South Africa
        1. 5.7.6.1. South Africa AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      7. 5.7.7. Rest of Middle-East Africa
        1. 5.7.7.1. Rest of Middle-East Africa AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
  6. Chapter 6 AI for Pharmaceutical Market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Developments
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. Chapter 7 Company Profiles
    1. 7.1. Pfizer
      1. 7.1.1. Company Overview
      2. 7.1.2. Product/Service Portfolio
      3. 7.1.3. Pfizer Sales, Revenue, and Gross Margin
      4. 7.1.4. Pfizer Revenue and Growth Rate
      5. 7.1.5. Pfizer Market Share
      6. 7.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 7.2. Janssen Pharmaceutical
      1. 7.2.1. Company Overview
      2. 7.2.2. Product/Service Portfolio
      3. 7.2.3. Janssen Pharmaceutical Sales, Revenue, and Gross Margin
      4. 7.2.4. Janssen Pharmaceutical Revenue and Growth Rate
      5. 7.2.5. Janssen Pharmaceutical Market Share
      6. 7.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 7.3. Sanofi
      1. 7.3.1. Company Overview
      2. 7.3.2. Product/Service Portfolio
      3. 7.3.3. Sanofi Sales, Revenue, and Gross Margin
      4. 7.3.4. Sanofi Revenue and Growth Rate
      5. 7.3.5. Sanofi Market Share
      6. 7.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 7.4. Novartis
      1. 7.4.1. Company Overview
      2. 7.4.2. Product/Service Portfolio
      3. 7.4.3. Novartis Sales, Revenue, and Gross Margin
      4. 7.4.4. Novartis Revenue and Growth Rate
      5. 7.4.5. Novartis Market Share
      6. 7.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 7.5. Bayer
      1. 7.5.1. Company Overview
      2. 7.5.2. Product/Service Portfolio
      3. 7.5.3. Bayer Sales, Revenue, and Gross Margin
      4. 7.5.4. Bayer Revenue and Growth Rate
      5. 7.5.5. Bayer Market Share
      6. 7.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 7.6. Takeda
      1. 7.6.1. Company Overview
      2. 7.6.2. Product/Service Portfolio
      3. 7.6.3. Takeda Sales, Revenue, and Gross Margin
      4. 7.6.4. Takeda Revenue and Growth Rate
      5. 7.6.5. Takeda Market Share
      6. 7.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 7.7. Roche
      1. 7.7.1. Company Overview
      2. 7.7.2. Product/Service Portfolio
      3. 7.7.3. Roche Sales, Revenue, and Gross Margin
      4. 7.7.4. Roche Revenue and Growth Rate
      5. 7.7.5. Roche Market Share
      6. 7.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 7.8. Merck
      1. 7.8.1. Company Overview
      2. 7.8.2. Product/Service Portfolio
      3. 7.8.3. Merck Sales, Revenue, and Gross Margin
      4. 7.8.4. Merck Revenue and Growth Rate
      5. 7.8.5. Merck Market Share
      6. 7.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 7.9. Glaxo SmithKline
      1. 7.9.1. Company Overview
      2. 7.9.2. Product/Service Portfolio
      3. 7.9.3. Glaxo SmithKline Sales, Revenue, and Gross Margin
      4. 7.9.4. Glaxo SmithKline Revenue and Growth Rate
      5. 7.9.5. Glaxo SmithKline Market Share
      6. 7.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 7.10. Eli Lilly
      1. 7.10.1. Company Overview
      2. 7.10.2. Product/Service Portfolio
      3. 7.10.3. Eli Lilly Sales, Revenue, and Gross Margin
      4. 7.10.4. Eli Lilly Revenue and Growth Rate
      5. 7.10.5. Eli Lilly Market Share
      6. 7.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 7.11. Astra Zeneca
      1. 7.11.1. Company Overview
      2. 7.11.2. Product/Service Portfolio
      3. 7.11.3. Astra Zeneca Sales, Revenue, and Gross Margin
      4. 7.11.4. Astra Zeneca Revenue and Growth Rate
      5. 7.11.5. Astra Zeneca Market Share
      6. 7.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 7.12. Allergan
      1. 7.12.1. Company Overview
      2. 7.12.2. Product/Service Portfolio
      3. 7.12.3. Allergan Sales, Revenue, and Gross Margin
      4. 7.12.4. Allergan Revenue and Growth Rate
      5. 7.12.5. Allergan Market Share
      6. 7.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  8. Chapter 8 AI for Pharmaceutical — Industry Analysis
    1. 8.1. Introduction and Taxonomy
    2. 8.2. AI for Pharmaceutical Market – Key Trends
      1. 8.2.1. Market Drivers
      2. 8.2.2. Market Restraints
      3. 8.2.3. Market Opportunities
    3. 8.3. Value Chain Analysis
    4. 8.4. Key Mandates and Regulations
    5. 8.5. Technology Roadmap and Timeline
    6. 8.6. AI for Pharmaceutical Market – Attractiveness Analysis
      1. 8.6.1. By Offering
      2. 8.6.2. By Technology
      3. 8.6.3. By Application
      4. 8.6.4. By Region
  9. Chapter 9 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 9.1. AI for Pharmaceutical Industrial Chain Analysis
    2. 9.2. Downstream Buyers
    3. 9.3. Distributors/Traders List
  10. Chapter 10 Marketing Strategy Analysis
    1. 10.1. Marketing Channel
    2. 10.2. Direct Marketing
    3. 10.3. Indirect Marketing
    4. 10.4. Marketing Channel Development Trends
    5. 10.5. Economic/Political Environmental Change
  11. Chapter 11 Report Conclusion & Key Insights
    1. 11.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 11.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  12. Chapter 12 Research Approach & Methodology
    1. 12.1. Report Description
    2. 12.2. Research Scope
    3. 12.3. Research Methodology
      1. 12.3.1. Secondary Research
      2. 12.3.2. Primary Research
      3. 12.3.3. Statistical Models
        1. 12.3.3.1. Company Share Analysis Model
        2. 12.3.3.2. Revenue Based Modeling
      4. 12.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of AI for Pharmaceutical
      Fig.2	Global AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.3	Global AI for Pharmaceutical Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
      Fig.4	Global AI for Pharmaceutical Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
      Fig.5	Global AI for Pharmaceutical Market Share, by Offering, 2019 & 2026 (USD Million)
      Fig.6	Global Software AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.7	Global Services AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.8	Global AI for Pharmaceutical Market Share, by Technology, 2019 & 2026 (USD Million)
      Fig.9	Global Context-Aware Processing AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.10	Global Natural Language Processing AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.11	Global Machine Learning AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.12	Global Deep Learning AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.13	Global AI for Pharmaceutical Market Share, by Application, 2019 & 2026 (USD Million)
      Fig.14	Global Drug Discovery AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.15	Global Research & Development AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.16	Global Diagnosis AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.17	Global Epidemic Prediction AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.18	Global Disease Prevention AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.19	Global Remote Monitoring AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.20	Global Manufacturing AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.21	Global Marketing AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.22	Global AI for Pharmaceutical Market Share, by Region, 2019 & 2026 (USD Million)
      Fig.23	North America AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.24	U.S. AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.25	Canada AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.26	Europe AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.27	Germany AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.28	France AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.29	U.K. AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.30	Italy AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.31	Spain AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.32	Rest of Europe AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.33	Asia Pacific AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.34	China AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.35	Japan AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.36	India AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.37	South  Korea AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.38	South-East Asia AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.39	Rest of Asia Pacific AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.40	Latin America AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.41	Brazil AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.42	Mexico AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.43	Rest of Latin America AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.44	The Middle-East and Africa AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.45	GCC Countries AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.46	South Africa AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.47	Rest of Middle-East Africa AI for Pharmaceutical Market, 2016 – 2026 (USD Million)
      Fig.48	Competitor Market Share – Revenue
      Fig.49	Pfizer Revenue and Growth Rate
      Fig.50	Pfizer Market Share
      Fig.51	Janssen Pharmaceutical Revenue and Growth Rate
      Fig.52	Janssen Pharmaceutical Market Share
      Fig.53	Sanofi Revenue and Growth Rate
      Fig.54	Sanofi Market Share
      Fig.55	Novartis Revenue and Growth Rate
      Fig.56	Novartis Market Share
      Fig.57	Bayer Revenue and Growth Rate
      Fig.58	Bayer Market Share
      Fig.59	Takeda Revenue and Growth Rate
      Fig.60	Takeda Market Share
      Fig.61	Roche Revenue and Growth Rate
      Fig.62	Roche Market Share
      Fig.63	Merck Revenue and Growth Rate
      Fig.64	Merck Market Share
      Fig.65	Glaxo SmithKline Revenue and Growth Rate
      Fig.66	Glaxo SmithKline Market Share
      Fig.67	Eli Lilly Revenue and Growth Rate
      Fig.68	Eli Lilly Market Share
      Fig.69	Astra Zeneca Revenue and Growth Rate
      Fig.70	Astra Zeneca Market Share
      Fig.71	Allergan Revenue and Growth Rate
      Fig.72	Allergan Market Share
      Fig.73	Market Dynamics
      Fig.74	Global AI for Pharmaceutical – Value Chain Analysis
      Fig.75	Key Mandates and Regulations
      Fig.76	Technology Roadmap and Timeline
      Fig.77	Market Attractiveness Analysis – By Offering
      Fig.78	Market Attractiveness Analysis – By Technology
      Fig.79	Market Attractiveness Analysis – By Application
      Fig.80	Market Attractiveness Analysis – By Region
      Fig.81	AI for Pharmaceutical Industrial Chain Analysis
      Fig.82	Market Channels
      Fig.83	Marketing Channel Development Trend
      Fig.84	Growth in World Gross Product, 2008-2018
      

      List of Tables

      Table 1 Global AI for Pharmaceutical Market, 2019 & 2026 (USD Million)
      Table 2 Global AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      Table 3 Global AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      Table 4 Global AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      Table 5 Global AI for Pharmaceutical Market, by Region, 2016 – 2026 (USD Million)
      Table 6 North America AI for Pharmaceutical Market, by Country, 2016 – 2026 (USD Million)
      Table 7 North America AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      Table 8 North America AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      Table 9 North America AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      Table 10 Europe AI for Pharmaceutical Market, by Country, 2016 – 2026 (USD Million)
      Table 11 Europe AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      Table 12 Europe AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      Table 13 Europe AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      Table 14 Asia Pacific AI for Pharmaceutical Market, by Country, 2016 – 2026 (USD Million)
      Table 15 Asia Pacific AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      Table 16 Asia Pacific AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      Table 17 Asia Pacific AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      Table 18 Latin America AI for Pharmaceutical Market, by Country, 2016 – 2026 (USD Million)
      Table 19 Latin America AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      Table 20 Latin America AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      Table 21 Latin America AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      Table 22 The Middle-East and Africa AI for Pharmaceutical Market, by Country, 2016 – 2026 (USD Million)
      Table 23 The Middle-East and Africa AI for Pharmaceutical Market, by Offering, 2016 – 2026 (USD Million)
      Table 24 The Middle-East and Africa AI for Pharmaceutical Market, by Technology, 2016 – 2026 (USD Million)
      Table 25 The Middle-East and Africa AI for Pharmaceutical Market, by Application, 2016 – 2026 (USD Million)
      Table 26 Global AI for Pharmaceutical Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
      Table 27 Global AI for Pharmaceutical Market - Company Revenue Share Analysis, 2016 – 2019 (%)
      Table 28 Acquisitions and Mergers
      Table 29 Market Drivers – Impact Analysis
      Table 30 Market Restraints
      Table 31 Market Opportunities
      Table 32 Major Buyers of AI for Pharmaceutical
      Table 33 Distributors/Traders of AI for Pharmaceutical by Region
      

Industry Major Market Players

  • Pfizer
  • Janssen Pharmaceutical
  • Sanofi
  • Novartis
  • Bayer
  • Takeda
  • Roche
  • Merck
  • Glaxo SmithKline
  • Eli Lilly
  • Astra Zeneca
  • Allergan 

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions